It's T-ALL about Notch

Oncogene

Volumn 27, Issue 38, 2008, Pages 5082-5091

  Demarest, R M ^a   Ratti, F ^a   Capobianco, A J ^a  

^a WISTAR INSTITUTE   (United States)

Author keywords

C myc; CSL; Fbw7; Ikaros; p53; PTEN

Indexed keywords

IKAROS TRANSCRIPTION FACTOR; PROTEIN P53; TUMOR SUPPRESSOR PROTEIN;

ACUTE LYMPHOBLASTIC LEUKEMIA; APOPTOSIS; CELL CYCLE; DISEASE COURSE; GENE MUTATION; HUMAN; PRIORITY JOURNAL; PROTEIN INTERACTION; PROTEIN TARGETING; REVIEW; T LYMPHOCYTE;

ANIMALS; APOPTOSIS; CELL CYCLE; F-BOX PROTEINS; GENE EXPRESSION REGULATION, LEUKEMIC; GENES, TUMOR SUPPRESSOR; HUMANS; IKAROS TRANSCRIPTION FACTOR; LEUKEMIA-LYMPHOMA, ADULT T-CELL; LIGANDS; MICE; MICE, TRANSGENIC; NEOPLASM PROTEINS; ONCOGENES; PTEN PHOSPHOHYDROLASE; RECEPTORS, NOTCH; SIGNAL TRANSDUCTION; T-LYMPHOCYTES; TUMOR SUPPRESSOR PROTEIN P53; TUMOR SUPPRESSOR PROTEINS; UBIQUITIN-PROTEIN LIGASES;

EID: 50849085425     PISSN: 09509232     EISSN: 14765594     Source Type: Journal    
DOI: 10.1038/onc.2008.222     Document Type: Review

References (85)

1. Aifantis I, Raetz E, Buonamici S. (2008). Molecular pathogenesis of T-cell leukaemia and lymphoma. Nat Rev Immunol 8:380-390.
2. Amati B, Alevizopoulos K, Vlach J. (1998). Myc and the cell cycle. Front Biosci 3:d250-d268.
3. Barata JT, Cardoso AA, Nadler LM, Boussiotis VA. (2001). Interleukin-7 promotes survival and cell cycle progression of T-cell acute lymphoblastic leukemia cells by down-regulating the cyclin-dependent kinase inhibitor p27(kip1). Blood 98:1524-1531.
4. Bellavia D, Mecarozzi M, Campese AF, Grazioli P, Gulino A, Screpanti I. (2007a). Notch and Ikaros:not only converging players in T cell leukemia. Cell Cycle 6:2730-2734.
5. Bellavia D, Mecarozzi M, Campese AF, Grazioli P, Talora C, Frati L et al. (2007b). Notch3 and the Notch3-upregulated RNA-binding protein HuD regulate Ikaros alternative splicing. EMBO J 26:1670-1680.
6. Beverly LJ, Capobianco AJ. (2003). Perturbation of Ikaros isoform selection by MLV integration is a cooperative event in Notch(IC)-induced T cell leukemogenesis. Cancer Cell 3:551-564.
7. Beverly LJ, Capobianco AJ. (2004). Targeting promiscuous signaling pathways in cancer:another Notch in the bedpost. Trends Mol Med 10:591-598.
8. Beverly LJ, Felsher DW, Capobianco AJ. (2005). Suppression of p53 by Notch in lymphomagenesis:implications for initiation and regression. Cancer Res 65:7159-7168.
9. Blain SW, Montalvo E, Massague J. (1997). Differential interaction of the cyclin-dependent kinase (Cdk) inhibitor p27Kip1 with cyclin A-Cdk2 and cyclin D2-Cdk4. J Biol Chem 272:25863-25872.
10. Brooks CL, Gu W. (2006). p53 ubiquitination:Mdm2 and beyond. Mol Cell 21:307-315.
11. Brou C, Logeat F, Gupta N, Bessia C, LeBail O, Doedens JR et al. (2000). A novel proteolytic cleavage involved in Notch signaling: the role of the disintegrin-metalloprotease TACE. Mol Cell 5:207-216.
12. Dang CV, Resar LM, Emison E, Kim S, Li Q, Prescott JE et al. (1999). Function of the c-Myc oncogenic transcription factor. Exp Cell Res 253:63-77.
13. Dohda T, Maljukova A, Liu L, Heyman M, Grander D, Brodin D et al. (2007). Notch signaling induces SKP2 expression and promotes reduction of p27Kip1 in T-cell acute lymphoblastic leukemia cell lines. Exp Cell Res 313:3141-3152.
14. Dou S, Zeng X, Cortes P, Erdjument-Bromage H, Tempst P, Honjo T et al. (1994). The recombination signal sequence-binding protein RBP-2N functions as a transcriptional repressor. Mol Cell Biol 14:3310-3319.
15. Dumortier A, Jeannet R, Kirstetter P, Kleinmann E, Sellars M, dos Santos NR et al. (2006). Notch activation is an early and critical event during T-cell leukemogenesis in Ikaros-deficient mice. Mol Cell Biol 26:209-220.
16. Eischen CM, Weber JD, Roussel MF, Sherr CJ, Cleveland JL. (1999). Disruption of the ARF-Mdm2-p53 tumor suppressor pathway in Myc-induced lymphomagenesis. Genes Dev 13:2658-2669.
17. Ellisen LW, Bird J, West DC, Soreng AL, Reynolds TC, Smith SD et al. (1991). TAN-1, the human homolog of the Drosophila notch gene, is broken by chromosomal translocations in T lymphoblastic neoplasms. Cell 66:649-661.
18. Ferrando AA, Neuberg DS, Staunton J, Loh ML, Huard C, Raimondi SC et al. (2002). Gene expression signatures define novel oncogenic pathways in T cell acute lymphoblastic leukemia. Cancer Cell 1:75-87.
19. Fortini ME, Artavanis-Tsakonas S. (1994). The suppressor of hairless protein participates in notch receptor signaling. Cell 79:273-282.
20. Fryer CJ, Lamar E, Turbachova I, Kintner C, Jones KA. (2002). Mastermind mediates chromatin-specific transcription and turnover of the Notch enhancer complex. Genes Dev 16:1397-1411.
21. Fryer CJ, White JB, Jones KA. (2004). Mastermind recruits CycC:CDK8 to phosphorylate the Notch ICD and coordinate activation with turnover. Mol Cell 16:509-520.
22. Georgopoulos K, Bigby M, Wang JH, Molnar A, Wu P, Winandy S et al. (1994). The Ikaros gene is required for the development of all lymphoid lineages. Cell 79:143-156.
23. Georgopoulos K, Moore DD, Derfler B. (1992). Ikaros, an early lymphoid-specific transcription factor and a putative mediator for T cell commitment. Science 258:808-812.
24. Girard L, Hanna Z, Beaulieu N, Hoemann CD, Simard C, Kozak CA et al. (1996). Frequent provirus insertional mutagenesis of Notch1 in thymomas of MMTVD/myc transgenic mice suggests a collaboration of c-myc and Notch1 for oncogenesis. Genes Dev 10:1930-1944.
25. Goldberg JM, Silverman LB, Levy DE, Dalton VK, Gelber RD, Lehmann L et al. (2003). Childhood T-cell acute lymphoblastic leukemia:the Dana-Farber Cancer Institute acute lymphoblastic leukemia consortium experience. J Clin Oncol 21:3616-3622.
26. Gordon WR, Vardar-Ulu D, Histen G, Sanchez-Irizarry C, Aster JC, Blacklow SC. (2007). Structural basis for autoinhibition of Notch. Nat Struct Mol Biol 14:295-300.
27. Grabher C, von Boehmer H, Look AT. (2006). Notch 1 activation in the molecular pathogenesis of T-cell acute lymphoblastic leukaemia. Nat Rev Cancer 6:347-359.
28. Guo W, Lasky JL, Chang CJ, Mosessian S, Lewis X, Xiao Y et al. (2008). Multi-genetic events collaboratively contribute to Pten-null leukaemia stem-cell formation. Nature 453:529-533.
29. Gupta-Rossi N, Le Bail O, Gonen H, Brou C, Logeat F, Six E et al. (2001). Functional interaction between SEL-10, an F-box protein, and the nuclear form of activated Notch1 receptor. J Biol Chem 276:34371-34378.
30. Hahm K, Ernst P, Lo K, Kim GS, Turck C, Smale ST. (1994). The lymphoid transcription factor LyF-1 is encoded by specific, alternatively spliced mRNAs derived from the Ikaros gene. Mol Cell Biol 14:7111-7123.
31. Hermeking H, Eick D. (1994). Mediation of c-Myc-induced apoptosis by p53. Science 265:2091-2093.
32. Hsieh JJ, Henkel T, Salmon P, Robey E, Peterson MG, Hayward SD. (1996). Truncated mammalian Notch1 activates CBF1/RBPJk-repressed genes by a mechanism resembling that of Epstein-Barr virus EBNA2. Mol Cell Biol 16:952-959.
33. Jeffries S, Robbins DJ, Capobianco AJ. (2002). Characterization of a high-molecular-weight Notch complex in the nucleus of Notch(ic)-transformed RKE cells and in a human T-cell leukemia cell line. Mol Cell Biol 22:3927-3941.
34. Kathrein KL, Chari S, Winandy S. (2008). Ikaros directly represses the notch target gene Hes1 in a leukemia T cell line: implicat ions for CD4 regulation. J Biol Chem 283:10476-10484.
35. Koch U, Radtke F. (2007). Notch and cancer: a double-edged sword. Cell Mol Life Sci 64:2746-2762.
36. Levine AJ, Hu W, Feng Z. (2006). The P53 pathway: what questions remain to be explored? Cell Death Differ 13:1027-1036.
37. Lopez-Nieva P, Santos J, Fernandez-Piqueras J. (2004). Defective expression of Notch1 and Notch2 in connection to alterations of c-Myc and Ikaros in gamma-radiation-induced mouse thymic lymphomas. Carcinogenesis 25:1299-1304.
38. Malecki MJ, Sanchez-Irizarry C, Mitchell JL, Histen G, Xu ML, Aster JC et al. (2006). Leukemia-associated mutations within the NOTCH1 heterodimerization domain fall into at least two distinct mechanistic classes. Mol Cell Biol 26:4642-4651.
39. Marcu KB, Bossone SA, Patel AJ. (1992). myc function and regulation. Annu Rev Biochem 61:809-860.
40. Matsuoka S, Oike Y, Onoyama I, Iwama A, Arai F, Takubo K et al. (2008). Fbxw7 acts as a critical fail-safe against premature loss of hematopoietic stem cells and development of T-ALL. Genes Dev 22:986-991.
41. Mayo LD, Dixon JE, Durden DL, Tonks NK, Donner DB. (2002). PTEN protects p53 from Mdm2 and sensitizes cancer cells to chemotherapy. J Biol Chem 277:5484-5489.
42. Meek DW, Knippschild U. (2003). Posttranslational modification of MDM2. Mol Cancer Res 1:1017-1026.
43. Molnar A, Georgopoulos K. (1994). The Ikaros gene encodes a family of functionally diverse zinc finger DNA-binding proteins. Mol Cell Biol 14:8292-8303.
44. Mumm JS, Kopan R. (2000). Notch signaling:from the outside in. Dev Biol 228:151-165.
45. Mumm JS, Schroeter EH, Saxena MT, Griesemer A, Tian X, Pan DJ et al. (2000). A ligand-induced extracellular cleavage regulates gamma-secretase-like proteolytic activation of Notch1. Mol Cell 5:197-206.
46. Murata K, Hattori M, Hirai N, Shinozuka Y, Hirata H, Kageyama R et al. (2005). Hes1 directly controls cell proliferation through the transcriptional repression of p27Kip1. Mol Cell Biol 25:4262-4271.
47. Nguyen BC, Lefort K, Mandinova A, Antonini D, Devgan V, Della Gatta G et al. (2006). Cross-regulation between Notch and p63 in keratinocyte commitment to differentiation. Genes Dev 20:1028-1042.
48. Nicolas M, Wolfer A, Raj K, Kummer JA, Mill P, van Noort M et al. (2003). Notch1 functions as a tumor suppressor in mouse skin. Nat Genet 33:416-421.
49. O'Neil J, Grim J, Strack P, Rao S, Tibbitts D, Winter C et al. (2007). FBW7 mutations in leukemic cells mediate NOTCH pathway activation and resistance to gamma-secretase inhibitors. J Exp Med 204:1813-1824.
50. Oberg C, Li J, Pauley A, Wolf E, Gurney M, Lendahl U. (2001). The Notch intracellular domain is ubiquitinated and negatively regulated by the mammalian Sel-10 homolog. J Biol Chem 276:35847-35853.
51. Palomero T, Sulis ML, Cortina M, Real PJ, Barnes K, Ciofani M et al. (2007). Mutational loss of PTEN induces resistance to NOTCH1 inhibition in T-cell leukemia. Nat Med 13:1203-1210.
52. Pui CH, Sandlund JT, Pei D, Campana D, Rivera GK, Ribeiro RC et al. (2004). Improved outcome for children with acute lymphoblastic leukemia:results of Total Therapy Study XIIIB at St Jude Children's Research Hospital. Blood 104:2690-2696.
53. Qi R, An H, Yu Y, Zhang M, Liu S, Xu H et al. (2003). Notch1 signaling inhibits growth of human hepatocellular carcinoma through induction of cell cycle arrest and apoptosis. Cancer Res 63:8323-8329.
54. Rebay I, Fleming RJ, Fehon RG, Cherbas L, Cherbas P, Artavanis-Tsakonas S. (1991). Specific EGF repeats of Notch mediate interactions with Delta and Serrate:implications for Notch as a multifunctional receptor. Cell 67:687-699.
55. Ronchini C, Capobianco AJ. (2000). Notch(ic)-ER chimeras display hormone-dependent transformation, nuclear accumulation, phosphorylation and CBF1 activation. Oncogene 19:3914-3924.
56. Roy M, Pear WS, Aster JC. (2007). The multifaceted role of Notch in cancer. Curr Opin Genet Dev 17:52-59.
57. Sanchez-Irizarry C, Carpenter AC, Weng AP, Pear WS, Aster JC, Blacklow SC. (2004). Notch subunit heterodimerization and prevention of ligand-independent proteolytic activation depend, respectively, on a novel domain and the LNR repeats. Mol Cell Biol 24:9265-9273.
58. Satoh Y, Matsumura I, Tanaka H, Ezoe S, Sugahara H, Mizuki M et al. (2004). Roles for c-Myc in self-renewal of hematopoietic stem cells. J Biol Chem 279:24986-24993 .
59. Schroeter EH, Kisslinger JA, Kopan R. (1998). Notch-1 signalling requires ligand-induced proteolytic release of intracellular domain. Nature 393:382-386.
60. Sharma VM, Calvo JA, Draheim KM, Cunningham LA, Hermance N, Beverly L et al. (2006). Notch1 contributes to mouse T-cell leukemia by directly inducing the expression of c-myc. Mol Cell Biol 26:8022-8031.
61. Sheaff RJ, Groudine M, Gordon M, Roberts JM, Clurman BE. (1997). Cyclin E-CDK2 is a regulator of p27Kip1. Genes Dev 11:1464-1478.
62. Sherr CJ. (1998). Tumor surveillance via the ARF-p53 pathway. Genes Dev 12:2984-2991.
63. Sherr CJ. (2006). Divorcing ARF and p53:an unsettled case. Nat Rev Cancer 6:663-673.
64. Sherr CJ, Roberts JM. (1999). CDK inhibitors:positive and negative regulators of G1-phase progression. Genes Dev 13:1501-1512.
65. Sicinska E, Aifantis I, Le Cam L, Swat W, Borowski C, Yu Q et al. (2003). Requirement for cyclin D3 in lymphocyte development and T cell leukemias. Cancer Cell 4:451-461.
66. Sriuranpong V, Borges MW, Ravi RK, Arnold DR, Nelkin BD, Baylin SB et al. (2001). Notch signaling induces cell cycle arrest in small cell lung cancer cells. Cancer Res 61:3200-3205.
67. Stahl M, Ge C, Shi S, Pestell RG, Stanley P. (2006). Notch1-induced transformation of RKE-1 cells requires up-regulation of cyclin D1. Cancer Res 66:7562-7570.
68. Struhl G, Adachi A. (1998). Nuclear access and action of notch in vivo. Cell 93:649-660.
69. Sun L, Crotty ML, Sensel M, Sather H, Navara C, Nachman J et al. (1999a). Expression of dominant-negative Ikaros isoforms in T-cell acute lymphoblastic leukemia. Clin Cancer Res 5:2112-2120.
70. Sun L, Goodman PA, Wood CM, Crotty ML, Sensel M, Sather H et al. (1999b). Expression of aberrantly spliced oncogenic ikaros isoforms in childhood acute lymphoblastic leukemia. J Clin Oncol 17:3753-3766.
71. Sun L, Heerema N, Crotty L, Wu X, Navara C, Vassilev A et al. (1999c). Expression of dominant-negative and mutant isoforms of the antileukemic transcription factor Ikaros in infant acute lymphoblastic leukemia. Proc Natl Acad Sci USA 96:680-685.
72. Sun L, Liu A, Georgopoulos K. (1996). Zinc finger-mediated protein interactions modulate Ikaros activity, a molecular control of lymphocyte development. EMBO J 15:5358-5369.
73. Suzuki A, de la Pompa JL, Stambolic V, Elia AJ, Sasaki T, del Barco Barrantes I et al. (1998). High cancer susceptibility and embryonic lethality associated with mutation of the PTEN tumor suppressor gene in mice. Curr Biol 8:1169-1178.
74. Tamura K, Taniguchi Y, Minoguchi S, Sakai T, Tun T, Furukawa T et al. (1995). Physical interaction between a novel domain of the receptor Notch and the transcription factor RBP-J kappa/Su(H). Curr Biol 5:1416-1423.
75. Thiel E, Kranz BR, Raghavachar A, Bartram CR, Loffler H, Messerer D et al. (1989). Prethymic phenotype and genotype of pre-T (CD7+/ER-)-cell leukemia and its clinical significance within adult acute lymphoblastic leukemia. Blood 73:1247-1258.
76. Thompson BJ, Jankovic V, Gao J, Buonamici S, Vest A, Lee JM et al. (2008). Control of hematopoietic stem cell quiescence by the E3 ubiquitin ligase Fbw7. J Exp Med 205:1395-1408.
77. Tsukiyama T, Ishida N, Shirane M, Minamishima YA, Hatakeyama S, Kitagawa M et al. (2001). Down-regulation of p27Kip1 expression is required for development and function of T cells. J Immunol 166:304-312.
78. Uren AG, Kool J, Matentzoglu K, de Ridder J, Mattison J, van Uitert M et al. (2008). Large-scale mutagenesis in p19(ARF)- and p53-deficient mice identifies cancer genes and their collaborative networks. Cell 133:727-741.
79. Waltzer L, Bourillot PY, Sergeant A, Manet E. (1995). RBP-J kappa repression activity is mediated by a co-repressor and antagonized by the Epstein-Barr virus transcription factor EBNA2. Nucleic Acids Res 23:4939-4945.
80. Welcker M, Clurman BE. (2008). FBW7 ubiquitin ligase:a tumour suppressor at the crossroads of cell division, growth and differentiation. Nat Rev Cancer 8:83-93.
81. Weng AP, Ferrando AA, Lee W, Morris IV JP, Silverman LB, Sanchez-Irizarry C et al. (2004). Activating mutations of NOTCH1 in human T cell acute lymphoblastic leukemia. Science 306:269-271.
82. Weng AP, Millholland JM, Yashiro-Ohtani Y, Arcangeli ML, Lau A, Wai C et al. (2006). c-Myc is an important direct target of Notch1 in T-cell acute lymphoblastic leukemia/lymphoma. Genes Dev 20:2096-2109.
83. Winandy S, Wu P, Georgopoulos K. (1995). A dominant mutation in the Ikaros gene leads to rapid development of leukemia and lymphoma. Cell 83:289-299.
84. Wu L, Aster JC, Blacklow SC, Lake R, Artavanis-Tsakonas S, Griffin JD. (2000). MAML1, a human homologue of Drosophila mastermind, is a transcriptional co-activator for NOTCH receptors. Nat Genet 26:484-489.
85. Zhou BP, Liao Y, Xia W, Zou Y, Spohn B, Hung MC. (2001). HER-2/neu induces p53 ubiquitination via Akt-mediated MDM2 phosphorylation. Nat Cell Biol 3:973-982.